In the treatment of psoriasis, secukinumab was found superior to several contemporary biological agents currently used, such as etanercept and ustekinumab.[17] Etanercept[26] is a tumor necrosis factor antagonist approved for the treatment of psoriatic arthritis and psoriasis. Here, TNF is linked to psoriasis.